Analytical chemistry of synthetic routes to psychoactive tryptamines: Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS

Analyst

Volumn 129, Issue 11, 2004, Pages 1047-1057

  Brandt, Simon D ^a   Freeman, Sally ^a   Fleet, Ian A ^a   McGagh, Peter ^a   Alder, John F ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (5 METHOXY 1H INDOL 3 YL)ETHANOL; 2 N,N DIISOPROPYLAMINO 1 (5 METHOXY 1H INDOL 3 YL)ETHANOL; 2 N,N DIISOPROPYLAMINO 1 (5 METHOXY 1H INDOL 3 YL)ETHANONE; 3 (2 N,N DIISOPROPYLAMINOETHYL) 1H INDOL 5 OL; N,N DIISOPROPYL 5 METHOXYTRYPTAMINE; PSYCHOTROPIC AGENT; TRYPTAMINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; FLOW INJECTION ANALYSIS; FORENSIC SCIENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; SPEETER AND ANTHONY PROCEDURE; TECHNIQUE;

EID: 8844246411     PISSN: 00032654     EISSN: None     Source Type: Journal    
DOI: 10.1039/b407239c     Document Type: Article

References (47)

1. A. T. Shulgin and M. F. Carter, Commun. Psychopharmacol., 1980, 4, 363.
2. A. T. Shulgin and A. Shulgin, TIHKAL: The Continuation, Transform Press, Berkeley, 1997.
3. http://www.erowid.org/chemicals/5meo_dipt/5meo_dipt_effects.shtml.
4. R. Meatherall and P. Sharma, J. Anal. Toxicol, 2003, 27, 313.
5. B. W. Clare, Aust. J. Chem., 1995, 48, 1385.
6. G. Beuerle, K. A. Kovar and M. Schulze-Alexandru, Quant. Struct. Act. Relat., 1997, 16, 447.
7. A. T. Shulgin and A. Shulgin, PIHKAL. A Chemical Love Story, Transform Press, Berkeley, 1991.
8. R. A. Glennon, R. Young, J. M. Jacyno, M. Slusher and J. A. Rosecrans, Eur. J. Pharmacol., 1983, 86, 453.
9. A. T. Shulgin in Hallucinogens. A Forensic Drug Handbook, ed. R. R. Laing, Elsevier Science Ltd., London, 2003, p. 67.
10. D. J. McKenna, G. H. Towers and F. S. Abbott, J. Ethnopharmacol., 1984, 12, 179.
11. Identification and Determination of Impurities in Drugs, ed. S. Görög, Elsevier Science B. V., Amsterdam, 2000.
12. R. J. Strassman, J. Psychoactive Drugs, 1991, 23, 29.
13. R. Strassman, NIDA Res. Monogr., 1994, 146, 92.
14. S. Freeman and J. F. Alder, Identification of the chemical precursors of illicit synthetic drugs. Final Report on Contract ETD/99/502245 to Commission of the European Communities, Enterprise DG-Chemicals Unit. 2000.
15. S. Freeman and J. F. Alder, Eur. J. Med. Chem., 2002, 37, 527.
16. R. J. Sundberg, Indoles, Academic Press, London, 1996.
17. G. W. Gribble, Contemp. Org. Synth., 1994, 1, 145.
18. G. W. Gribble, J. Chem. Soc. Perkin Trans. 1, 2000, 1045.
19. T. L. Gilchrist, J. Chem. Soc. Perkin Trans. 1, 2001, 2491.
20. M. E. Specter and W. C. Anthony, J. Am. Chem. Soc., 1954, 76, 6208.
21. C. Q. Meng, S. Rakhit, D. K. H. Lee, R. Kambo, K. L. McCallum, L. Mazzocco, K. Dyne and A. Slassi, Bioorg. Med. Chem. Lett., 2000, 10, 903.
22. A. Slassi, L. Edwards, A. O'Brien, C. Q. Meng, T. Xin, C. Seto, D. K. H. Lee, N. MacLean, D. Hynd, C. Chen, H. Wang, R. Kamboj and S. Rakhit, Bioorg. Med. Chem. Lett., 2000, 10, 1707.
23. M. Katagi, H. Tsutsumi, A. Miki, K. Nakajima and H. Tsuchihashi, Jpn. J. Forensic Toxicol., 2002, 20, 303.
24. J. Hugel, J. Meyers and D. Lankin in Hallucinogens. A Forensic Drug Handbook, ed. R. R. Laing, Elsevier Science Ltd., London, 2003, p. 191.
25. W. M. A. Niessen, J. Chromatogr. A, 1998, 794, 407.
26. W. M. A. Niessen, J. Chromatogr. A, 2003, 1000, 413.
27. J. L. Neumeyer, U. V. Moyer and J. E. Leonard, J. Med. Chem., 1969, 12, 450.
28. J. Gynther, P. Peura and S. Salmi, Acta Chem. Scand. B., 1985, 39, 849.
29. G. Bertaccini and T. Vitali, Farmaco, 1967, 22, 229.
30. G. J. Shaw, G. J. Wright and G. W. Milne, Biomed. Mass. Spectrom., 1977, 4, 348.
31. J. A. Ballantine, C. B. Barrett, R. J. S. Beer, B. G. Boggiano, K. Clarke, S. Eardley, B. E. Jennings and A. Robertson, J. Chem. Soc., 1957, 2222.
32. T. Kralt, W. J. Asma, H. H. Haeck and H. D. Moed, Rec. Trav. Chim., 1961, 80, 313.
33. Patent, DE 2609289 (1976).
34. G. J. Shaw, G. J. Wright and G. W. Milne, Biomed. Mass. Spectrom., 1976, 3, 146.
35. M. Julia and P. Manoury, Bull. Soc. Chim. France, 1965, 5, 1411.
36. W. F. Smyth, V. N. Ramachandran, E. O'Kane and D. Coulter, Anal. Bioanal. Chem., 2004, 375, 1305.
37. W. F. Smyth, C. Joyce, V. N. Ramachandran, E. O'Kane and D. Coulter, Anal. Chim. Acta, 2004, 506, 203.
38. S. McClean, R. C. Robinson, C. Shaw and W. F. Smyth, Rapid Commun. Mass Spectrom., 2002, 16, 346.
39. F. M. Xie, P. Wong, K. Yoshioka, R. G. Cooks and P. T. Kissinger, J. Liq. Chromatogr. Relat. Technol., 1998, 21, 1273.
40. L. M. Jackman in Dynamic Nuclear Magnetic Resonance Spectroscopy, ed. L. M. Jackman and F. A. Cotton, Academic Press, New York, 1975, p. 203.
41. D. B. Repke, W. J. Ferguson and D. K. Bates, J. Heterocycl. Chem., 1977, 14, 71.
42. D. B. Repke, W. J. Ferguson and D. K. Bates, J. Heterocycl. Chem., 1981, 18, 175.
43. D. B. Grotjahn, J. Heterocycl. Chem., 1983, 20, 1031.
44. M. Spaeth, P. Plischka, F. M. Bohnen, R. Herbst-Irmer and H. Laatsch, J. Prakt. Chem., 1997, 339, 243.
45. J. S. Cowie, A. L. Holtham and L. V. Jones, J. Forensic Sci., 1982, 27, 527.
46. R. V. Heinzelman and J. Szmuszkovicz, Progr. Drug Res., 1963, 6, 75.
47. D. L. Crookes, K. P. Parry and G. F. Smith, Pol. J. Chem., 1979, 53, 73.